Cardiovascular risk and all-cause mortality attributable to diabetes: Tehran Lipid and Glucose Study

被引:0
作者
M. Bozorgmanesh
F. Hadaegh
F. Sheikholeslami
F. Azizi
机构
[1] Shahid Beheshti University of Medical Sciences,Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences
来源
Journal of Endocrinological Investigation | 2012年 / 35卷
关键词
All-cause mortality; cardiovascular disease; diabetes; population attributable fraction; risk;
D O I
暂无
中图分类号
学科分类号
摘要
Aim: To quantify the burden of cardiovascular diseases (CVD), and all-cause mortality attributable to diabetes. Subjects and methods: Data on an 8.6-yr follow-up of 6331 participants (2741 men), free of CVD at baseline, were analyzed to determine the burden of CVD and all-cause mortality attributable to self-reported and screen-detected diabetes mellitus (SRDM and SDDM, respectively). Risks of events of interest were separately assessed for women and men using Cox-proportional-hazard model. Results: The mean age at baseline was 47 yr with 997 (15.7%) of participants having diabetes (men 14.8%, women 16.5%). SRDM and SDDM prevailed in 9.7% (men 9.2, women 10.2%) and 6.0% of participants (men 5.7, women 6.3%), respectively. During follow up (52,404 person-yr), we observed 447 incident cases of CVD [387 had coronary heart disease (CHD)] and 209 deaths. Among men, participants with SDDM had increased relative hazard for all-cause mortality translated to a population attributable risk fraction (PAF) of 10.1%. Among women, SDDM was associated with CVD and CHD but not with all-cause mortality; so that 9.3% and 8.8% of CVD and CHD events were respectively attributable to the SDDM. If SRDM had been eliminated from the population, the incidences of CVD, CHD, and death would have decreased by 10.5, 9.5, and 17.3% in men; and 22.0, 24.2, and 17.8% in women, respectively. Conclusion: SDDM and SRDM have high PAF for all-cause mortality and CVD. Besides diabetes treatment and prevention, screening to detect undiagnosed diabetes should warrant high priority among the public health strategies to lower the incidence of CVD and mortality.
引用
收藏
页码:14 / 20
页数:6
相关论文
共 50 条
[11]   Fasting glucose variability in young adulthood and incident diabetes, cardiovascular disease and all-cause mortality [J].
Bancks, Michael P. ;
Carson, April P. ;
Lewis, Cora E. ;
Gunderson, Erica P. ;
Reis, Jared P. ;
Schreiner, Pamela J. ;
Yano, Yuichiro ;
Carnethon, Mercedes R. .
DIABETOLOGIA, 2019, 62 (08) :1366-1374
[12]   Glucose patterns during an oral glucose tolerance test and associations with future diabetes, cardiovascular disease and all-cause mortality rate [J].
Hulman, Adam ;
Vistisen, Dorte ;
Glumer, Charlotte ;
Bergman, Michael ;
Witte, Daniel R. ;
Faerch, Kristine .
DIABETOLOGIA, 2018, 61 (01) :101-107
[13]   Predictors of all-cause and cardiovascular disease mortality in type 2 diabetes: Diabetes Heart Study [J].
Raffield, Laura M. ;
Hsu, Fang-Chi ;
Cox, Amanda J. ;
Carr, J. Jeffrey ;
Freedman, Barry I. ;
Bowden, Donald W. .
DIABETOLOGY & METABOLIC SYNDROME, 2015, 7
[14]   Association of cumulative blood glucose load with cardiovascular risk and all-cause mortality [J].
Tian, Xue ;
Chen, Shuohua ;
Zhang, Yijun ;
Zhang, Xiaoli ;
Xu, Qin ;
Xia, Xue ;
Wang, Penglian ;
Luo, Yanxia ;
Wu, Shouling ;
Wang, Anxin .
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2023, 17 (12)
[15]   Physical Activity, All-Cause and Cardiovascular Mortality, and Cardiovascular Disease [J].
Kraus, William E. ;
Powell, Kenneth E. ;
Haskell, William L. ;
Janz, Kathleen F. ;
Campbell, Wayne W. ;
Jakicic, John M. ;
Troiano, Richard P. ;
Sprow, Kyle ;
Torres, Andrea ;
Piercy, Katrina L. ;
Buchner, David M. ;
DiPietro, Loretta ;
Erickson, Kirk, I ;
Hillman, Charles H. ;
Katzmarzyk, Peter T. ;
King, Abby C. ;
Macko, Richard F. ;
Marquez, David X. ;
McTieman, Anne ;
Pate, Russell R. ;
Pescatello, Linda S. ;
Whitt-Glover, Melicia C. .
MEDICINE & SCIENCE IN SPORTS & EXERCISE, 2019, 51 (06) :1270-1281
[16]   Time course of the triglyceride glucose index accumulation with the risk of cardiovascular disease and all-cause mortality [J].
Tian, Xue ;
Chen, Shuohua ;
Zhang, Yijun ;
Zhang, Xiaoli ;
Xu, Qin ;
Wang, Penglian ;
Wu, Shouling ;
Wang, Anxin ;
Luo, Yanxia .
CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
[17]   Time course of the triglyceride glucose index accumulation with the risk of cardiovascular disease and all-cause mortality [J].
Xue Tian ;
Shuohua Chen ;
Yijun Zhang ;
Xiaoli Zhang ;
Qin Xu ;
Penglian Wang ;
Shouling Wu ;
Anxin Wang ;
Yanxia Luo .
Cardiovascular Diabetology, 21
[18]   Sulphonylurea-metformin combination therapy, cardiovascular disease and all-cause mortality: the Fremantle Diabetes Study [J].
Sillars, B. ;
Davis, W. A. ;
Hirsch, I. B. ;
Davis, T. M. E. .
DIABETES OBESITY & METABOLISM, 2010, 12 (09) :757-765
[19]   Predictive Value of Triglyceride-Glucose Index for All-Cause and Cardiovascular Mortality in Patients With Diabetes Mellitus: A Retrospective Study [J].
Feng, Xiaoxuan ;
Deng, Yishou ;
Chen, Chaolei ;
Liu, Xiaocong ;
Huang, Yuqing ;
Feng, Yingqing .
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2024, 2024
[20]   PhenoAgeAccel is associated with all-cause and cardiovascular mortality in patients with diabetes and prediabetes: A cohort study [J].
Xi, Junyu ;
Zhang, Zeyu ;
Hou, Baoluo ;
Wu, Yuqi ;
Zhang, Yifei ;
Liu, Weijing .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2025, 226